Triple-negative breast cancer: current perspective on the evolving therapeutic landscape

Triple-negative breast cancer (TNBC) is known to have a poor prognosis and limited treatment options, namely chemotherapy. Different molecular studies have recently classified TNBC into different subtypes opening the door to potential new-targeted treatment options. In this review, we discuss the cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehanna, Joe, Haddad, Fady GH, Eid, Roland, Lambertini, Matteo, Kourie, Hampig Raphael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682754/
https://www.ncbi.nlm.nih.gov/pubmed/31447592
http://dx.doi.org/10.2147/IJWH.S178349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682754/
https://www.ncbi.nlm.nih.gov/pubmed/31447592
http://dx.doi.org/10.2147/IJWH.S178349

Ejemplares similares